Now live: Pro — the full 13F research suite for serious investorsSee pricing →
22NW, LP

Q2 2023 · 13F-HR

22NW, LPholdings as filed

Filed 2023-08-14 · accession 0001214659-23-011293

$160.1M
Reported value
14
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
859241101STRLSTERLING INFRASTRUCTURE INC$33.5M20.9%601,201CommonSOLE
L72967109OECORION S.A.$21.0M13.1%988,708CommonSOLE
350060109FSTRFOSTER L B CO$18.7M11.7%1,313,121CommonSOLE
514766104LFCRLIFECORE BIOMEDICAL INC$17.0M10.6%1,755,161CommonSOLE
068463108BBSIBARRETT BUSINESS SVCS INC$15.5M9.70%178,173CommonSOLE
034569103ANEBANEBULO PHARMACEUTICALS INC$11.9M7.44%5,066,290CommonSOLE
563571405MTWMANITOWOC CO INC$11.5M7.19%611,058CommonSOLE
230215105CULPCULP INC$6.0M3.76%1,212,380CommonSOLE
19260Q957COINBASE GLOBAL INC$5.8M3.60%2,310PUTSOLE
25490H106DRTTFDIRTT ENVIRONMENTAL SOLUTION$5.7M3.53%21,356,410CommonSOLE
307675108FB1FARMER BROS CO$5.4M3.38%1,955,526CommonSOLE
71742W103PFXPHENIXFIN CORP$4.5M2.80%117,885CommonSOLE
86272A206SSKNEURSTRATA SKIN SCIENCES INC$3.3M2.04%3,439,261CommonSOLE
53000N108LIANYLIANBIO$321,9880.20%141,223CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.